Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Finasteride effectively treats male hair loss, increasing length and thickness.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Hair loss is linked to heart disease and metabolic syndrome, and while current treatments vary in effectiveness, more research is needed for better solutions.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More research needed to confirm finasteride as standard treatment for FFA.